TY  - CONF 
AU  - Gómez-Reino Carnota, Juan Jesús
PY  - 2013
SN  - 0340-1855
UR  - http://hdl.handle.net/20.500.11940/3940
LA  - eng
TI  - Long-term (52-week) results of a phase 3, randomized, controlled trial of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis (PALACE 1)
VL  - 72
ER  -